17856-2170-2 : NDC 2026 Code

17856-2170-2 : Acyclovir ( Acyclovir Suspension )

Additionally :

You can get information about “17856-2170-2” NDC code in 17856-2170-2 in HTML format

HTML | 17856-2170-2 in TXT (Plain Text) format

TXT | 17856-2170-2 in PDF (Portable Document Format)

PDF | 17856-2170-2 in XML format

XML formats.

NDC Code : 17856-2170-2 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "17856-2170-2",
    "PackageDescription": "72 CUP, UNIT-DOSE in 1 CASE (17856-2170-2)  / 10 mL in 1 CUP, UNIT-DOSE",
    "NDC11Code": "17856-2170-02",
    "ProductNDC": "17856-2170",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Acyclovir Suspension",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Acyclovir",
    "DosageFormName": "SUSPENSION",
    "RouteName": "ORAL",
    "StartMarketingDate": "20230309",
    "EndMarketingDate": null,
    "MarketingCategoryName": "ANDA",
    "ApplicationNumber": "ANDA217393",
    "LabelerName": "Atlantic Biologicals Corp.",
    "SubstanceName": "ACYCLOVIR",
    "StrengthNumber": "200",
    "StrengthUnit": "mg/5mL",
    "Pharm_Classes": "DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2026-05-06",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20271231",
    "StartMarketingDatePackage": "20260504",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}